pancreas disease News
-
NuMedii Announces Research Collaboration With Leading Academic Research Institution to Explore New Targets and Therapeutics for Pancreatitis
SAN MATEO, Calif., November 1, 2018 – NuMedii, Inc., today announced the formation of a research collaboration with Johns Hopkins School of Medicine with the goal of discovering new targets and therapeutic options for pancreatitis. The collaboration brings together deep clinical expertise with NuMedii’s Artificial Intelligence Drug Discovery (AIDD) technology, which will enable the ...
-
Kidney and Pancreas Function Diagnostic Enzymes Are Now Available at Creative Enzymes
Creative Enzymes, a global leader in diagnostic enzyme manufacturing and supply, is dedicated to offering a wide range of enzyme products as well as customized enzyme-related services for medical and research diagnosis. Recently, Creative Enzymes launched kidney and pancreas function diagnostic enzymes for the global market. The primary function of the kidney is to eliminate waste and excess ...
-
NeoTherma Oncology Announces FDA Granted Its Vectron Thermal Device for Treatment of Pancreatic Cancer Breakthrough Device Designation within Expedited Access Pathway
NeoTherma Oncology, (NTO) a privately held medical device company developing novel non-invasive treatments for solid tumors, today announces that the United States Food and Drug Administration (FDA) has granted the company's petition to admit its Vectron TTx treatment for Pancreatic Cancer as Breakthrough Device under FDA's Expedited Access Pathway (EAP). Signed by President Obama in December ...
-
Creative Enzymes Upgrades Multiple Diagnostic Enzyme Products for Clinical and Diagnostic Research
Creative Enzymes, the world’s leading diagnostic enzyme production company, has been committed to providing customers with various enzyme products and services for medical and research diagnosis. Relying on its professional team and the most advanced technology, as well as high-quality products and services, it has gained solid reputation. Recently, Creative Enzymes has announced multiple ...
-
G-Tech Medical Receives FDA Clearance for its Gastrointestinal Motility Monitoring System
MOUNTAIN VIEW, Calif., January 13, 2022 – G-Tech Medical, a developer of non-invasive diagnostic solutions for patients with gastrointestinal disorders, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Wireless Patch System (WPS) for non-invasive myoelectric activity measurement. The G-Tech WPS is a tool that provides gastric and intestinal myoelectrical ...
-
Israeli Startup Wants to Cure Diabetes by Making Micro-pancreases. It Worked on Mice
Never mind better insulin shots or cell implants for diabetics: Betalin Therapeutics has a unique approach. A young Israeli company that has cured type-1 diabetes in mice and hopes to do the same for humans one day has won the MIXiii Biomed 2017 pharma startup competition, beating dozens of other firms. Just how cured were these mice, exactly? “They were cured of advanced stages of severe ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you